184 related articles for article (PubMed ID: 37707761)
1. Myeloid sarcoma and pathological fracture: a case report and review of literature.
Takeyasu S; Morita K; Saito S; Toho M; Oyama T; Obo T; Taoka K; Shimura A; Maki H; Shibata E; Watanabe Y; Suzuki F; Zhang L; Kobayashi H; Hinata M; Kurokawa M
Int J Hematol; 2023 Dec; 118(6):745-750. PubMed ID: 37707761
[TBL] [Abstract][Full Text] [Related]
2. Myeloid sarcoma: more and less than a distinct entity.
Loscocco GG; Vannucchi AM
Ann Hematol; 2023 Aug; 102(8):1973-1984. PubMed ID: 37286874
[TBL] [Abstract][Full Text] [Related]
3. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
Kanagal-Shamanna R; Bueso-Ramos CE; Barkoh B; Lu G; Wang S; Garcia-Manero G; Vadhan-Raj S; Hoehn D; Medeiros LJ; Yin CC
Cancer; 2012 Jun; 118(11):2879-88. PubMed ID: 22038701
[TBL] [Abstract][Full Text] [Related]
4. Isolated pancreatic myeloid sarcoma: A potential mimicker of pancreatic adenocarcinoma.
Soni A; Jindal S; Narang V; Singh A; Paul D; Kaur H
Indian J Pathol Microbiol; 2022; 65(3):676-678. PubMed ID: 35900500
[TBL] [Abstract][Full Text] [Related]
5. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
6. Detection of the KIT
Craig JW; Hasserjian RP; Kim AS; Aster JC; Pinkus GS; Hornick JL; Steensma DP; Coleman Lindsley R; DeAngelo DJ; Morgan EA
Mod Pathol; 2020 Jun; 33(6):1135-1145. PubMed ID: 31896808
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
8. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features.
Aqil B; Sukhanova M; Behdad A; Jennings L; Lu X; Chen Q; Chen YH; Gao J
Hum Pathol; 2022 Nov; 129():81-89. PubMed ID: 36087739
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation.
Nagamine M; Miyoshi H; Kawamoto K; Takeuchi M; Yamada K; Yanagida E; Kohno K; Ohshima K
Pathology; 2022 Jun; 54(4):442-448. PubMed ID: 34852914
[TBL] [Abstract][Full Text] [Related]
10. Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.
Patnaik MM; Lasho TL; Finke CM; Knudson RA; Ketterling RP; Chen D; Hoyer JD; Hanson CA; Tefferi A
Am J Hematol; 2011 May; 86(5):393-8. PubMed ID: 21523797
[TBL] [Abstract][Full Text] [Related]
11. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
Leguit RJ; Orazi A; Kucine N; Kvasnicka HM; Gianelli U; Arber DA; Porwit A; Ponzoni M
Virchows Arch; 2022 Oct; 481(4):621-646. PubMed ID: 35819517
[TBL] [Abstract][Full Text] [Related]
12. The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology.
Paulsson K; Säll T; Fioretos T; Mitelman F; Johansson B
Cancer Genet Cytogenet; 2001 Oct; 130(2):160-5. PubMed ID: 11675138
[TBL] [Abstract][Full Text] [Related]
13. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
14. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.
Schnittger S; Bacher U; Haferlach C; Alpermann T; Dicker F; Sundermann J; Kern W; Haferlach T
Leukemia; 2011 Apr; 25(4):615-21. PubMed ID: 21233837
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
17. [Isolated myeloid sarcoma involving the mediastinum].
Jelić-Puskarić B; Kardum-Skelin I; Sustercić D; Pazur M; Vrhovac R; Radić-Kristo D; Gredelj-Simec N; Kovacević DO; Plasćak J; Gasparov S; Jaksić B
Acta Med Croatica; 2011 Sep; 65 Suppl 1():133-8. PubMed ID: 23126041
[TBL] [Abstract][Full Text] [Related]
18. Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Kok CH; Yeung DT; Hiwase DK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396733
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
20. Myeloid sarcoma involving the breast.
Jelić-Puskarić B; Ostojić-Kolonić S; Planinc-Peraica A; Obad-Kovacević D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Jun; 34(2):641-4. PubMed ID: 20698144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
